Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets

Islet amyloid and beta cell death in type 2 diabetes are heterogeneous events, where some islets are affected early in the disease process, whereas others remain visibly unaffected. This study investigated the possibility that inter-islet functional and vascular differences may explain the propensit...

Full description

Bibliographic Details
Main Authors: Sara Ullsten, Sara Bohman, Marie E Oskarsson, K Peter R Nilsson, Gunilla T Westermark, Per-Ola Carlsson
Format: Article
Language:English
Published: Bioscientifica 2017-09-01
Series:Endocrine Connections
Subjects:
Online Access:http://www.endocrineconnections.com/content/6/7/458.full
id doaj-96a24516c7114072b89f9897f9232a8a
record_format Article
spelling doaj-96a24516c7114072b89f9897f9232a8a2020-11-24T21:46:00ZengBioscientificaEndocrine Connections2049-36142049-36142017-09-016745846810.1530/EC-17-0148Islet amyloid deposits preferentially in the highly functional and most blood-perfused isletsSara Ullsten0Sara Bohman1Marie E Oskarsson2K Peter R Nilsson3Gunilla T Westermark4Per-Ola Carlsson5Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Chemistry, Linköping University, Linköping, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, SwedenIslet amyloid and beta cell death in type 2 diabetes are heterogeneous events, where some islets are affected early in the disease process, whereas others remain visibly unaffected. This study investigated the possibility that inter-islet functional and vascular differences may explain the propensity for amyloid accumulation in certain islets. Highly blood-perfused islets were identified by microspheres in human islet amyloid polypeptide expressing mice fed a high-fat diet for three or 10 months. These highly blood-perfused islets had better glucose-stimulated insulin secretion capacity than other islets and developed more amyloid deposits after 10 months of high-fat diet. Similarly, human islets with a superior release capacity formed more amyloid in high glucose culture than islets with a lower release capacity. The amyloid formation in mouse islets was associated with a higher amount of prohormone convertase 1/3 and with a decreased expression of its inhibitor proSAAS when compared to islets with less amyloid. In contrast, levels of prohormone convertase 2 and expression of its inhibitor neuroendocrine protein 7B2 were unaltered. A misbalance in prohormone convertase levels may interrupt the normal processing of islet amyloid polypeptide and induce amyloid formation. Preferential amyloid load in the most blood-perfused and functional islets may accelerate the progression of type 2 diabetes.http://www.endocrineconnections.com/content/6/7/458.fullislet amyloidpancreatic isletsheterogeneityblood flow
collection DOAJ
language English
format Article
sources DOAJ
author Sara Ullsten
Sara Bohman
Marie E Oskarsson
K Peter R Nilsson
Gunilla T Westermark
Per-Ola Carlsson
spellingShingle Sara Ullsten
Sara Bohman
Marie E Oskarsson
K Peter R Nilsson
Gunilla T Westermark
Per-Ola Carlsson
Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
Endocrine Connections
islet amyloid
pancreatic islets
heterogeneity
blood flow
author_facet Sara Ullsten
Sara Bohman
Marie E Oskarsson
K Peter R Nilsson
Gunilla T Westermark
Per-Ola Carlsson
author_sort Sara Ullsten
title Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
title_short Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
title_full Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
title_fullStr Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
title_full_unstemmed Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
title_sort islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
publisher Bioscientifica
series Endocrine Connections
issn 2049-3614
2049-3614
publishDate 2017-09-01
description Islet amyloid and beta cell death in type 2 diabetes are heterogeneous events, where some islets are affected early in the disease process, whereas others remain visibly unaffected. This study investigated the possibility that inter-islet functional and vascular differences may explain the propensity for amyloid accumulation in certain islets. Highly blood-perfused islets were identified by microspheres in human islet amyloid polypeptide expressing mice fed a high-fat diet for three or 10 months. These highly blood-perfused islets had better glucose-stimulated insulin secretion capacity than other islets and developed more amyloid deposits after 10 months of high-fat diet. Similarly, human islets with a superior release capacity formed more amyloid in high glucose culture than islets with a lower release capacity. The amyloid formation in mouse islets was associated with a higher amount of prohormone convertase 1/3 and with a decreased expression of its inhibitor proSAAS when compared to islets with less amyloid. In contrast, levels of prohormone convertase 2 and expression of its inhibitor neuroendocrine protein 7B2 were unaltered. A misbalance in prohormone convertase levels may interrupt the normal processing of islet amyloid polypeptide and induce amyloid formation. Preferential amyloid load in the most blood-perfused and functional islets may accelerate the progression of type 2 diabetes.
topic islet amyloid
pancreatic islets
heterogeneity
blood flow
url http://www.endocrineconnections.com/content/6/7/458.full
work_keys_str_mv AT saraullsten isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
AT sarabohman isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
AT marieeoskarsson isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
AT kpeterrnilsson isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
AT gunillatwestermark isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
AT perolacarlsson isletamyloiddepositspreferentiallyinthehighlyfunctionalandmostbloodperfusedislets
_version_ 1725902688812531712